Mayer Brown has advised new client Oxford BioDynamics Plc (“OBD”), an Oxford University spin-out, on its admission to AIM with an expected market capitalization of £136 million.

Gide advised CDC International Capital via Future French Champions, the partnership with the Qatari sovereign fund Qatar Investment Authority (QIA), on the EUR 100 million fund raising of Devialet, alongside Ginko Ventures, CM-CIC Investissement,  Korelya Capital, Foxconn, Naver, Renault Playground Global, Roc Nation and Bpifrance Investissement.

Vinge advises Swedbank AB (publ) in connection with two share issues in Brinova Fastigheter AB (publ), both a rights issue of shares of class B amounting to approximately SEK 210 million, as well as a share issue of shares of class B to the general public, amounting to approximately SEK 48 million, with deviation from the shareholders pre-emption rights. A prospectus was published on 29 November 2016. Brinova Fastigheter is listed on Nasdaq First North Premier.

Vinge’s team consists of Jesper Schönbeck and Nils Fredrik Dehlin.

Travers Smith LLP has acted for Investec Bank plc in its capacity as sponsor, financial adviser, bookrunner and broker on the £94 million placing and open offer of new ordinary shares issued by Sanne Group plc.

Sanne is a specialist provider of outsourced corporate, fund and private client administration, reporting and fiduciary services.  The proceeds of the placing are to be primarily utilised by Sanne to fund the Class 1 acquisition of the IFS Group, a Mauritius-based fund administration business.

Macfarlanes has advised GHO Capital on the fundraising of its first healthcare private equity fund which has closed with commitments of €660m.

Norton Rose Fulbright has advised Beijing Capital Juda Limited (Capital Juda) on the issue of a combination of new ordinary shares and perpetual convertible bond securities to two strategic and financial investors, Sino-Ocean Group Holding Limited and KKR, for a total consideration of HKD1.477 billion under a specific mandate to be sought from its shareholders.

The shares in Volati AB (publ) have on 30 November 2016 been admitted to trading on Nasdaq Stockholm. In connection with the listing, the general public in Sweden and qualified investors were offered newly issued ordinary shares corresponding to approximately 24 per cent of the total number of ordinary shares in the company.

In addition to the offering of ordinary shares, Volati’s preference shares, which have been traded on Nasdaq First North Premier since June 2015, were admitted to trading on Nasdaq Stockholm.

Simpson Thacher represented Charterhouse Capital Partners in connection with all aspects of the fund raising for Charterhouse Capital Partners X (“CCP X”), a €2.3 billion private equity fund which held a final closing.

CCP X will invest in mid-to-large market buyouts in Western Europe.

The Simpson Thacher team advising Charterhouse included Gareth Earl, Jason Glover, Daniel Lloyd, Alex Westbrook and Catherine Kidd (Corporate); Meredith Jones, Joseph Tootle and Jacqueline Clinton (Tax); and Jeanne Annarumma (ERISA).

Davis Polk advised the joint book-running managers and representatives of the underwriters in the $200 million public offering by BeiGene, Ltd. of 6,250,000 American Depositary Shares, of which 5,781,250 ADSs were issued and sold by BeiGene and 468,750 ADSs were sold by certain selling shareholders. The ADSs are listed on the NASDAQ Global Select Market under the symbol “BGNE.”

BeiGene is a global, clinical-stage, research-based biotechnology company focused on targeted and immuno-oncological therapeutics.

Setterwalls has advised Serneke Group AB (publ) in connection with its IPO on Nasdaq Stockholm. Carnegie Investment Bank AB (Carnegie) was Global Coordinator in the offering.